Literature DB >> 8390825

Species selective interaction of Alphaherpesvirinae with the "unspecific" immune system of the host.

H P Huemer1, C Larcher, S van Drunen Littel-van den Hurk, L A Babiuk.   

Abstract

During evolution Herpesviridae have developed glycoproteins, which interact with essential components of the immune system. Besides immunoglobulin-binding proteins (= Fc-receptors), expressed by several members of the herpesfamily, the interaction with the complement system plays a role in the pathogenicity of herpes simplex virus. Here we report that the ability to interact with the third complement component (C3), the central mediator of complement activation, was also found among several animal alphaherpesviruses. This interaction appeared to be species-selective as the viral proteins preferentially bound to the C3 originated from the respective host. That could provide a possible explanation for the evolution of a variety of herpesviruses as the species tropism observed among Herpesviridae may be influenced by specific adaptation of protective virus-proteins to the immune system of the different hosts. The data have critical implications for the studies of virus host interactions in heterologous systems and support a role for the C3-binding proteins in pathogenesis. Since the C3-binding proteins are conserved among different herpesviruses they could serve as suitable subunit-vaccine candidates.

Mesh:

Substances:

Year:  1993        PMID: 8390825     DOI: 10.1007/bf01309666

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  37 in total

1.  Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation.

Authors:  J A van Strijp; K P van Kessel; L A Miltenburg; A C Fluit; J Verhoef
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

Review 2.  The multifunctional role of C3, the third component of complement.

Authors:  J D Lambris
Journal:  Immunol Today       Date:  1988-12

3.  The gene encoding the gIII envelope protein of pseudorabies virus vaccine strain Bartha contains a mutation affecting protein localization.

Authors:  A K Robbins; J P Ryan; M E Whealy; L W Enquist
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

4.  Cell surface expression of the varicella-zoster virus glycoproteins and Fc receptor.

Authors:  V Litwin; M Sandor; C Grose
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

5.  Studies on glycoprotein 13 (gp13) of equid herpesvirus 1 using affinity-purified gp13, glycoprotein-specific monoclonal antibodies and synthetic peptides in a hamster model.

Authors:  A Stokes; A H Corteyn; L A Pullen; T R Doel; D M Meredith; R A Killington; I W Halliburton; G R Whittaker; L A Wheldon; L Nicolson
Journal:  J Gen Virol       Date:  1991-04       Impact factor: 3.891

6.  Glycoprotein C of herpes simplex virus type 1 is essential for the virus to evade antibody-independent complement-mediated virus inactivation and lysis of virus-infected cells.

Authors:  Y Hidaka; Y Sakai; Y Toh; R Mori
Journal:  J Gen Virol       Date:  1991-04       Impact factor: 3.891

7.  Factors influencing the interaction of herpes simplex virus glycoprotein C with the third component of complement.

Authors:  H P Huemer; C Larcher; M P Dierich; D Falke
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

8.  Induction of receptors for complement and immunoglobulins by herpesviruses of various species.

Authors:  H B Ohmann; L A Babiuk
Journal:  Virus Res       Date:  1988-03       Impact factor: 3.303

9.  Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity.

Authors:  T A McNearney; C Odell; V M Holers; P G Spear; J P Atkinson
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

Review 10.  Complement, viruses, and virus-infected cells.

Authors:  N R Cooper; G R Nemerow
Journal:  Springer Semin Immunopathol       Date:  1983
View more
  17 in total

1.  Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity.

Authors:  Mark A Brockman; David M Knipe
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Marek's disease virus expresses multiple UL44 (gC) variants through mRNA splicing that are all required for efficient horizontal transmission.

Authors:  Keith W Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compared to immunization with gD alone.

Authors:  Sita Awasthi; John M Lubinski; Carolyn E Shaw; Shana M Barrett; Michael Cai; Fushan Wang; Michael Betts; Susan Kingsley; Daniel J Distefano; John W Balliet; Jessica A Flynn; Danilo R Casimiro; Janine T Bryan; Harvey M Friedman
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

4.  Further analysis of Marek's disease virus horizontal transmission confirms that U(L)44 (gC) and U(L)13 protein kinase activity are essential, while U(S)2 is nonessential.

Authors:  Keith W Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

Review 5.  BHV-1: new molecular approaches to control a common and widespread infection.

Authors:  L Turin; S Russo; G Poli
Journal:  Mol Med       Date:  1999-05       Impact factor: 6.354

6.  Synthesis, processing, and oligomerization of bovine herpesvirus 1 gE and gI membrane proteins.

Authors:  J C Whitbeck; A C Knapp; L W Enquist; W C Lawrence; L J Bello
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  Immune evasion properties of herpes simplex virus type 1 glycoprotein gC.

Authors:  H M Friedman; L Wang; N O Fishman; J D Lambris; R J Eisenberg; G H Cohen; J Lubinski
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

8.  In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor.

Authors:  T Nagashunmugam; J Lubinski; L Wang; L T Goldstein; B S Weeks; P Sundaresan; E H Kang; G Dubin; H M Friedman
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine.

Authors:  Sita Awasthi; John M Lubinski; Harvey M Friedman
Journal:  Vaccine       Date:  2009-09-15       Impact factor: 3.641

10.  Immune evasion by herpes simplex virus type 1, strategies for virus survival.

Authors:  Harvey M Friedman
Journal:  Trans Am Clin Climatol Assoc       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.